COVID-19에 의한 후각장애의 최신 지견
The pandemic of coronavirus disease 2019 (COVID-19) is an extreme threat to international health care, resulting in more than two million deaths. Data reveal that olfactory disorder is a characteristic symptom of COVID-19 and has unique clinical manifestations. The olfactory dysfunction induced by C...
Saved in:
| Published in | Journal of rhinology pp. 73 - 80 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | Korean |
| Published |
대한비과학회
01.07.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1229-1498 2384-4361 |
| DOI | 10.18787/jr.2020.00346 |
Cover
| Summary: | The pandemic of coronavirus disease 2019 (COVID-19) is an extreme threat to international health care, resulting in more than two million deaths. Data reveal that olfactory disorder is a characteristic symptom of COVID-19 and has unique clinical manifestations. The olfactory dysfunction induced by COVID-19 has sudden onset, short duration, and rapid recovery, with anosmia often the only symptom. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) affects the human body by binding to angiotensin converting enzyme 2 (ACE2) of the olfactory epithelium. However, the etiology of COVID-19-induced olfactory dysfunction is unclear. In many countries, vaccines for COVID-19 in human are beginning to be administered. Conventional conservative treatments are common for olfactory disorders caused by COVID-19. Rhinologists should be aware of olfactory dysfunction to avoid delayed diagnosis of COVID-19. The article reviews the latest scientific evidence of anosmia in COVID-19. KCI Citation Count: 0 |
|---|---|
| Bibliography: | https://www.j-rhinology.org/journal/view.php?number=711 |
| ISSN: | 1229-1498 2384-4361 |
| DOI: | 10.18787/jr.2020.00346 |